Fierce Healthcare reports on a new payment model, the Enhancing Oncology Model, announced by the Centers for Medicare & Medicaid Services (CMS) on Monday, aimed at improving equity and care coordination for cancer treatments.
The Enhancing Oncology Model is a successor to the Oncology Care Model that ends in a few days. The new voluntary model will start in July 2023 and run through 2028.
The model will focus on beneficiaries that are “getting systemic chemotherapy for seven cancer types: breast cancer, chronic leukemia, small intestine/colorectal cancer, lung cancer, lymphoma, multiple myeloma and prostate cancer,” according to a fact sheet on the model.
Read more: